Orthocell easily raises $13 million

Nerve technology developer Orthocell (ASX:OCC) has received firm commitments from institutional investors to raise $13 million in a share placement. The company, which is commercialising its CellGro nerve regeneration product, received commitments for well in excess of the figure sought from existing and new investors. The company will also proceed with a share purchase plan…

First Australian medicinal cannabis produced in Queensland

THC Global Group (ASX:THC) has completed the first farm-to-pharma processing of medicinal cannabis in Australia at its Southport manufacturing facility (pictured) in Queensland. The Southport Facility is the largest pharmaceutical bio-floral extraction facility in the Southern Hemisphere and is licenced and permitted to process medicinal cannabis. THC Global CEO Ken Charteris said: “Completing this Australian…

Chemistry means low-emission steelmaking alternatives remain a challenge: Bluescope boss

Widespread adoption of breakthrough low-emission steelmaking was a “considerable way off,” the CEO of Bluescope has said.   According to The Australian Financial Review, Mark Vasella said the steelmaking industry was striving to reduce its greenhouse gas emissions, and there were alternatives to using fossil fuel-based energy, but the traditional use of carbon required to…